Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the ATHRO registry

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F14%3A00076757" target="_blank" >RIV/00216224:14110/14:00076757 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11120/14:43908651

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.crvasa.2014.04.009" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2014.04.009</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2014.04.009" target="_blank" >10.1016/j.crvasa.2014.04.009</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the ATHRO registry

Popis výsledku v původním jazyce

Background The modern treatment of acute coronary syndromes includes early initiation of dual antiplatelet therapy (DAPT) and coronary angiography (CAG) followed by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Recently two new potent antiplatelet agents (ticagrelor and prasugrel) were introduced in clinical practice. The aim of this registry was to analyze the treatment strategies in two neighboring countries: Czech (CZ) and Slovak (SK) Republics. Patients and methods A total of 1541 patients was enrolled during one month period in 18 tertiary cardiac centers in CZ (n = 1026) and 6 centers in SK (n = 515). The mean age was 66 ? 12 years (CZ) vs. 63 ? 12 (SK), diabetes mellitus was present in 31.1% (CZ) and 32.6% (SK). Prior revascularization was reported in 21.9% (CZ) vs. 16.1% (SK). Results ST-segment elevation myocardial infarction (STEMI) was the final diagnosis in 51.9% (CZ) vs. 44.9% (SK), non-STEMI in 34.1% vs. 31.

Název v anglickém jazyce

Antiplatelet therapy in patients after an acute coronary syndrome: Comparison of the Czech and Slovak Republics Results of the ATHRO registry

Popis výsledku anglicky

Background The modern treatment of acute coronary syndromes includes early initiation of dual antiplatelet therapy (DAPT) and coronary angiography (CAG) followed by percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Recently two new potent antiplatelet agents (ticagrelor and prasugrel) were introduced in clinical practice. The aim of this registry was to analyze the treatment strategies in two neighboring countries: Czech (CZ) and Slovak (SK) Republics. Patients and methods A total of 1541 patients was enrolled during one month period in 18 tertiary cardiac centers in CZ (n = 1026) and 6 centers in SK (n = 515). The mean age was 66 ? 12 years (CZ) vs. 63 ? 12 (SK), diabetes mellitus was present in 31.1% (CZ) and 32.6% (SK). Prior revascularization was reported in 21.9% (CZ) vs. 16.1% (SK). Results ST-segment elevation myocardial infarction (STEMI) was the final diagnosis in 51.9% (CZ) vs. 44.9% (SK), non-STEMI in 34.1% vs. 31.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

BB - Aplikovaná statistika, operační výzkum

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

56

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

"e320"-"e324"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—